|
| Actos Lawsuit |
 |
submitted by riibric 160 days ago (via cibjonews.com) |
|
| The original warning on pioglitazone was based on an interim review of an ongoing epidemiological study of almost 200,000 diabetic patients by drugmaker Takeda, and came just days after France and Germany banned use of the drug. The analysis found a 1.4-fold increased risk of bladder cancer with two years of treatment, although the agency said the finding was of "nominal" significance. |
| |
| 0 Comments - More Info - Bury Topic: Writing and Blogging |
|
